GlaxoSmithKline, under activist pressure, gets some relief as Elliott won’t push for sale or slash R&D: report

GlaxoSmithKline, under activist pressure, gets some relief as Elliott won’t push for sale or slash R&D: report
fkansteiner
Thu, 05/27/2021 – 09:42